Tram Tran's Insider Trades & SAST Disclosures

Tram Tran's most recent trade in Arbutus Biopharma Corp was a trade of 41,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 25, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Arbutus Biopharma Corp
Tram Tran Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 41,000 41,000 - - Stock Option (Right to Buy)
Arbutus Biopharma Corp
Tram Tran Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Nov 2021 44,000 44,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades